The price of guidelines: Revising the national guidelines for managing Australian women with abnormal Pap smears

Sexual Health

Volumn 3, Issue 1, 2006, Pages 53-55

  Mitchell, Heather ^a  

^a VICTORIAN CYTOLOGY SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; DECISION MAKING; HEALTH STATUS; HUMAN; MEDICAL RESEARCH; PAPANICOLAOU TEST; PRACTICE GUIDELINE; SHORT SURVEY;

AUSTRALIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIRECT SERVICE COSTS; FEMALE; FINANCING, PERSONAL; GUIDELINES; HUMANS; MASS SCREENING; MEDICAL AUDIT; NATIONAL HEALTH PROGRAMS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33144456366     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH05027     Document Type: Short Survey

References (6)

1. Muir Gray JA. Evidence-based healthcare. 2nd edn. Edinburgh: Churchill Livingstone; 2001.
2. Screening to prevent cervical cancer: guidelines for the management of women with screen detected abnormalities. Canberra: AGPS; 2004.
3. National Health and Medical Research Council (NHMRC). A guide to the development, implementation, and evaluation of clinical practice guidelines. Canberra, NHMRC; 1999.
4. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. Available online at: www-dep.iarc.fr [verified February 2006].
5. Hirst GH, Ward JE. Clinical practice guidelines: reality bites. Med J Aust 2000; 172: 287-91.
6. Edmonds JP, Day RO, Bertouch JV. The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors. Med J Aust 2002; 176: 332-4.